USFDA gives tentative nod for Lupin diabetes drug Sitagliptin Ruchika Sharma16 Dec 2023 11:30 AM ISTSitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2...
Ahead of Sitagliptin going off-Patent, NPPA moves to fix retail price of its FDC Meghna A Singhania15 April 2022 5:22 PM ISTNew Delhi: With the popular antidiabetic drug Sitagliptin soon expected to go off-patent, the apex drug price regulator, National Pharmaceutical...
Unichem Labs diabetes drug Sitagliptin gets USFDA approval Ruchika Sharma11 July 2021 12:00 PM ISTSitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
